SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nutrition

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Bullish_Today11/1/2006 8:03:47 PM
   of 577
 
QualityStocks.net launches coverage of Martin Nutraceuticals, Inc. (MNCL.PK)

The Company is a development stage company that develops and markets natural/complimentary (Nutraceuticals) for joint pain and weight control to the general consumer. Martin's products increase the activity of the immune system and obesity controlusing patented and proprietary oral systemic enzymes.

Martin Nutraceuticals is quickly establishing itself as a category leader in the Nutraceuticals marketplace within the $68 million Nutraceutical market.

The Company is focused on providing a better health and lifestyle through natural products and the developer of Arthizyme(TM),a proven and effective natural arthritis treatment.

greg@QualityStocks.net

www.QualityStocks.net
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext